Your browser doesn't support javascript.
loading
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.
Di Bartolomeo, Martina; Stark, Tibor; Maurel, Oriana Maria; Iannotti, Fabio Arturo; Kuchar, Martin; Ruda-Kucerova, Jana; Piscitelli, Fabiana; Laudani, Samuele; Pekarik, Vladimir; Salomone, Salvatore; Arosio, Beatrice; Mechoulam, Raphael; Maccarrone, Mauro; Drago, Filippo; Wotjak, Carsten T; Di Marzo, Vincenzo; Vismara, Matteo; Dell'Osso, Bernardo; D'Addario, Claudio; Micale, Vincenzo.
Afiliación
  • Di Bartolomeo M; Faculty of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Teramo, Italy.
  • Stark T; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Neuronal Plasticity Research Group, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
  • Maurel OM; Neuronal Plasticity Research Group, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania, Italy.
  • Iannotti FA; Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Endocannabinoid Research Group, Naples, Italy.
  • Kuchar M; Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Prague, Czech Republic; National Institute of Mental Health, Klecany, Czech Republic.
  • Ruda-Kucerova J; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Piscitelli F; Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Endocannabinoid Research Group, Naples, Italy.
  • Laudani S; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania, Italy.
  • Pekarik V; Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Salomone S; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania, Italy.
  • Arosio B; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Fondazione Ca' Granda, IRCCS, Ospedale Maggiore Policlinico, Milan, Italy.
  • Mechoulam R; Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Maccarrone M; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; European Center for Brain Research, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Drago F; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania, Italy.
  • Wotjak CT; Neuronal Plasticity Research Group, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany; Boehringer Ingelheim Pharma GmbH & KO KG, Germany.
  • Di Marzo V; Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Endocannabinoid Research Group, Naples, Italy; Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic, Health, Université Laval, Quebec City, Canada; Joint International Unit on Chemical and Bio
  • Vismara M; Department of Biomedical and Clinical Sciences 'Luigi Sacco', University of Milan, Milan, Italy; Department of Mental Health, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Dell'Osso B; Department of Biomedical and Clinical Sciences 'Luigi Sacco', University of Milan, Milan, Italy; Department of Mental Health, ASST Fatebenefratelli-Sacco, Milan, Italy; "Aldo Ravelli" Research Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University o
  • D'Addario C; Faculty of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Teramo, Italy; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Electronic address: cdaddario@unite.it.
  • Micale V; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania, Italy; National Institute of Mental Health, Klecany, Czech Republic. Electronic address: vincenzomicale@inwind.it.
Pharmacol Res ; 164: 105357, 2021 02.
Article en En | MEDLINE | ID: mdl-33285233
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Tardíos de la Exposición Prenatal / Esquizofrenia / Dronabinol / Regulación de la Expresión Génica / Receptores de Dopamina D2 / Corteza Prefrontal / Receptor Cannabinoide CB1 Límite: Animals / Female / Humans / Male / Pregnancy Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Tardíos de la Exposición Prenatal / Esquizofrenia / Dronabinol / Regulación de la Expresión Génica / Receptores de Dopamina D2 / Corteza Prefrontal / Receptor Cannabinoide CB1 Límite: Animals / Female / Humans / Male / Pregnancy Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Países Bajos